Transaction #31572 · Form 4 · 0001213900-26-107184
YD Bio Ltd · Stock award · Restricted Share Units
YD Bio Ltd · Transacted September 30, 2026 · Filed October 6, 2026
What does this filing report?
An SEC Form 4 filing for YD Bio Ltd records a stock award involving Restricted Share Units on September 30, 2026. The reported quantity was 3,135. The filing date is October 6, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- YD Bio Ltd
- Company CIK
- 0002011674
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 3,135
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 3,135
- Ownership description
- Not reported
- SEC acceptance time
- Oct 6, 2026, 4:00 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Chang Kochi ↗
Director
CIK 0002126567
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Ordinary Shares
- Underlying quantity
- 3,135
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- Each restricted share unit ("RSU") represents a contingent right to receive one ordinary share, par value $0.0001 per share ("Ordinary Shares"), of YD Bio Limited.
- F2
- The RSUs were granted pursuant to the YD Bio Limited Equity Incentive Plan with an aggregate target grant date fair value of $60,000 on March 31, 2026 (the "Granted RSUs"). The Granted RSUs vest in four equal quarterly installments beginning March 31, 2026, with the number of RSUs subject to vesting to be determined on the applicable vesting date by dividing $15,000 by the seven (7) trading-day volume-weighted average price of the Company's Ordinary Shares ending on the trading day immediately prior to such vesting.
- F3
- The Reporting Person became entitled to a fixed number of RSUs on September 30, 2026 (the "Vesting Date").
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.